Known targets — ChEMBL curated mechanism
ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.77 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconic Acid SCHEMBL21835970 | 1.00 | LMNA (0.77) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL2266761 | 1.00 | LMNA (0.77) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL5861529 | 1.00 | LMNA (0.77) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL22653996 | 0.98 | LMNA (0.74) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL22653997 | 0.98 | LMNA (0.74) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL4165311 | 0.98 | LMNA (0.74) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL27096625 | 0.98 | LMNA (0.74) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL377417 | 0.98 | LMNA (0.74) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL14813276 | 0.96 | LMNA (0.84) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL17675382 | 0.96 | LMNA (0.77) | LMNAPDE4AL3MBTL1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116246119-B | 3D target detection method, electronic device and storage medium | 青岛科技大学 | 2026-05-15 | — | — | CN | claimed |
| EP-4709424-A1 | LYOPHILIZED PRODUCTS, PHARMACEUTICAL COMPOSITIONS, AND KITS COMPRISING DYE-PEPTIDE CONJUGATES AND DERIVATIVES | Integro Theranostics, LLC (US) | 2026-03-18 | — | — | EP | claimed |
| EP-4704601-A1 | DAIRY-ALTERNATIVE BEVERAGES WITH IMPROVED TASTE | The Coca-Cola Company (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4704600-A1 | DAIRY BEVERAGES WITH IMPROVED TASTE | The Coca-Cola Company (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260028561-A1 | EDIBLE ALCOHOL-CONTAINING SPHERES | CDJ Partners, LLC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4658090-A1 | SIAMENOSIDE I SWEETENED BEVERAGES WITH MOGROSIDE BLENDS | The Coca-Cola Company (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250359571-A1 | INSTANT FOOD POWDER COMPRISING PEA AND OAT PROTEINS AND NO DAIRY PROTEIN | NESTLE SA (CH) | 2025-11-27 | — | — | US | claimed |
| WO-2025233495-A1 | EDIBLE BEADS | KONINKLIJKE DOUWE EGBERTS B.V. (NL) | 2025-11-13 | — | — | WO | claimed |
| WO-2025233496-A1 | EDIBLE BEADS | KONINKLIJKE DOUWE EGBERTS B.V. (NL) | 2025-11-13 | — | — | WO | claimed |
| EP-4615235-A1 | EDIBLE BEADS COMPRISING A NON-DAIRY CREAMER | Koninklijke Douwe Egberts B.V. (NL) | 2025-09-17 | — | — | EP | claimed |
| US-20040101597-A1 | Calcium fortified acidic beverages | UNILAB PHARMATECH, LTD. (CN) | 2004-05-27 | — | — | US | claimed |
| US-20030000391-A1 | Organic nutritional formula | NATURE'S ONE, INC. | 2003-01-02 | — | — | US | claimed |
| US-20020065317-A1 | Calcium salt compositions having improved solubility and method for preparing them | NUTRAGAL LTD. (IL) | 2002-05-30 | — | — | US | claimed |
| EP-1130979-A1 | CALCIUM FORTIFIED JUICE-BASED NUTRITIONAL SUPPLEMENT | Abbott Laboratories (US) | 2001-09-12 | — | — | EP | claimed |
| EP-1124445-A1 | CALCIUM SALT COMPOSITIONS HAVING IMPROVED SOLUBILITY AND METHOD FOR PREPARING THEM | Nutragal Ltd. (IL) | 2001-08-22 | — | — | EP | claimed |
| US-6120814-A | BEVERAGE WITH SMOOTH TEXTURE, PLEASANT TASTE AND LIGHT, REFRESHING MOUTHFEEL; FREE OF CHEMICAL PESTICIDES, ANTIBIOTICS, HORMONES, HERBICIDES, NON-GENETICALLY MODIFIED PLANTS AND CHEMICAL SOLVENTS | NATURE'S ONE, INC. (US) | 2000-09-19 | — | — | US | claimed |
| US-6106874-A | CALCIUM FORTIFIED FRUIT BEVERAGES | ABBOTT LABORATORIES (US) | 2000-08-22 | — | — | US | claimed |
| WO-2000028838-A1 | CALCIUM FORTIFIED JUICE-BASED NUTRITIONAL SUPPLEMENT | ABBOTT LABORATORIES (US) | 2000-05-25 | — | — | WO | claimed |
| WO-2000024274-A1 | CALCIUM SALT COMPOSITIONS HAVING IMPROVED SOLUBILITY AND METHOD FOR PREPARING THEM | NUTRAGAL LTD. (IL) | 2000-05-04 | — | — | WO | claimed |
| WO-1999065337-A1 | DIETARY SUPPLEMENT FOR POST-MENOPAUSAL WOMEN | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 1999-12-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028561-A1 | EDIBLE ALCOHOL-CONTAINING SPHERES | CALD1, ADH1A, MUC1 | LMNA 2575/4885PDE4A 457/4885L3MBTL1 4641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.